Spectral Diagnostics (OTCMKTS:EDTXF) Stock Price Down 0.2% – Should You Sell?

Shares of Spectral Diagnostics Inc. (OTCMKTS:EDTXF) traded down 0.2% during mid-day trading on Wednesday . The stock traded as low as $0.94 and last traded at $0.94. Approximately 6,200 shares changed hands during mid-day trading, an increase of 12% from the average session volume of 5,541 shares. The stock had previously closed at $0.9420.

Spectral Diagnostics Stock Performance

The company has a 50 day simple moving average of $0.99 and a 200 day simple moving average of $0.99. The company has a market capitalization of $275.83 million, a PE ratio of -9.40 and a beta of 0.11.

Spectral Diagnostics (OTCMKTS:EDTXF) last released its earnings results on Friday, May 8th. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01). The firm had revenue of $0.64 million during the quarter, compared to analysts’ expectations of $0.54 million.

About Spectral Diagnostics

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.